CEO
Piramal Pharma Limited
Equibles does not estimate personal net worth.
Nandini Piramal is recorded as CEO at Piramal Pharma Limited. Nandini Piramal has spoken on 1 earnings call across 1 company, most recently for Piramal Pharma Limited on October 28, 2026. Piramal Pharma Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“We delivered a strong performance in Q2 and H1 FY27 with broad-based contributions from all three businesses with a significant improvement in profitability. In Q2, revenue grew by 28% year-on-year to 2,617 crores, while EBITDA increased 72% to 385 crores.”
Piramal Pharma Limited
CEO
Transcript header (unverified)
Piramal Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Earnings Call
Piramal Pharma Limited
